An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial.
註釋
Next resistance: the $41 zone!Fundamentally, Pfizer Venture Investments has made 141 investments. Their most recent investment was on Jun 7, 2023, when Mozart Therapeutics raised $25M.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。